Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 3153

1.

Experiences, attitudes, and perceptions of caregivers of individuals with treatment-resistant schizophrenia: a qualitative study.

Brain C, Kymes S, DiBenedetti DB, Brevig T, Velligan DI.

BMC Psychiatry. 2018 Aug 13;18(1):253. doi: 10.1186/s12888-018-1833-5.

2.

Optimizing psychotherapy dosage for comorbid depression and personality disorders (PsyDos): a pragmatic randomized factorial trial using schema therapy and short-term psychodynamic psychotherapy.

Kool M, Van HL, Bartak A, de Maat SCM, Arntz A, van den Eshof JW, Peen J, Blankers M, Bosmans JE, Dekker JJM.

BMC Psychiatry. 2018 Aug 7;18(1):252. doi: 10.1186/s12888-018-1829-1.

3.

Effect of virtual reality aggression prevention training for forensic psychiatric patients (VRAPT): study protocol of a multi-center RCT.

Klein Tuente S, Bogaerts S, van IJzendoorn S, Veling W.

BMC Psychiatry. 2018 Aug 6;18(1):251. doi: 10.1186/s12888-018-1830-8.

4.

Community-based rehabilitation intervention for people with schizophrenia in Ethiopia (RISE): a 12 month mixed methods pilot study.

Asher L, Hanlon C, Birhane R, Habtamu A, Eaton J, Weiss HA, Patel V, Fekadu A, De Silva M.

BMC Psychiatry. 2018 Aug 3;18(1):250. doi: 10.1186/s12888-018-1818-4.

5.

Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study.

Mamakou V, Hackinger S, Zengini E, Tsompanaki E, Marouli E, Serafetinidis I, Prins B, Karabela A, Glezou E, Southam L, Rayner NW, Kuchenbaecker K, Lamnissou K, Kontaxakis V, Dedoussis G, Gonidakis F, Thanopoulou A, Tentolouris N, Zeggini E.

BMC Psychiatry. 2018 Aug 2;18(1):249. doi: 10.1186/s12888-018-1826-4.

6.

Heterozygous deletion of SCN2A and SCN3A in a patient with autism spectrum disorder and Tourette syndrome: a case report.

Nickel K, Tebartz van Elst L, Domschke K, Gläser B, Stock F, Endres D, Maier S, Riedel A.

BMC Psychiatry. 2018 Aug 2;18(1):248. doi: 10.1186/s12888-018-1822-8.

7.

Effectiveness of an intervention for managing victimization risks related to societal participation for persons with severe mental illness: a cluster RCT study protocol.

Albers WMM, Roeg DPK, Nijssen Y, Bongers IMB, van Weeghel J.

BMC Psychiatry. 2018 Aug 2;18(1):247. doi: 10.1186/s12888-018-1831-7.

8.

Hyperprolactinemia and insulin resistance in drug naive patients with early onset first episode psychosis.

Petruzzelli MG, Margari M, Peschechera A, de Giambattista C, De Giacomo A, Matera E, Margari F.

BMC Psychiatry. 2018 Aug 1;18(1):246. doi: 10.1186/s12888-018-1827-3.

9.

Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature.

Michaels TI, Purdon J, Collins A, Williams MT.

BMC Psychiatry. 2018 Jul 31;18(1):245. doi: 10.1186/s12888-018-1824-6.

10.

The prevalence of psychiatric disorders among students aged 6~ 16 years old in central Hunan, China.

Shen YM, Chan BSM, Liu JB, Zhou YY, Cui XL, He YQ, Fang YM, Xiang YT, Luo XR.

BMC Psychiatry. 2018 Jul 28;18(1):243. doi: 10.1186/s12888-018-1823-7.

11.

FT4 and TSH, relation to diagnoses in an unselected psychiatric acute-ward population, and change during acute psychiatric admission.

Sakai Y, Iversen V, Reitan SK.

BMC Psychiatry. 2018 Jul 28;18(1):244. doi: 10.1186/s12888-018-1819-3.

12.

Immunoglobulin sub-class distribution in bipolar disorder and schizophrenia: potential relationship with latent Toxoplasma Gondii infection.

Hamdani N, Bengoufa D, Godin O, Doukhan R, Le Guen E, Daban-Huard C, Bennabi M, Delavest M, Lépine JP, Boukouaci W, Laouamri H, Houenou J, Jamain S, Richard JR, Lecorvosier P, Yolken R, Rajagopal K, Leboyer M, Tamouza R.

BMC Psychiatry. 2018 Jul 27;18(1):239. doi: 10.1186/s12888-018-1821-9.

13.

Evaluating patterns and predictors of symptom change during a three-week intensive outpatient treatment for veterans with PTSD.

Zalta AK, Held P, Smith DL, Klassen BJ, Lofgreen AM, Normand PS, Brennan MB, Rydberg TS, Boley RA, Pollack MH, Karnik NS.

BMC Psychiatry. 2018 Jul 27;18(1):242. doi: 10.1186/s12888-018-1816-6.

14.

What might affect acceptability of online positive psychology interventions for depression: a qualitative study on patient expectations'.

Walsh S, Kaselionyte J, Taylor SJC, Priebe S.

BMC Psychiatry. 2018 Jul 27;18(1):240. doi: 10.1186/s12888-018-1812-x.

15.

Self-perceived level of competitiveness, tension and dependency and depression risk in the SUN cohort.

Lahortiga-Ramos F, Unzueta CR, Zazpe I, Santiago S, Molero P, Sánchez-Villegas A, Martínez-González MÁ.

BMC Psychiatry. 2018 Jul 27;18(1):241. doi: 10.1186/s12888-018-1804-x.

16.

Behavioral activation versus treatment as usual in naturalistic sample of psychiatric patients with depressive symptoms: a benchmark controlled trial.

Luoto KE, Lindholm LH, Paavonen V, Koivukangas A, Lassila A, Leinonen E, Kampman O.

BMC Psychiatry. 2018 Jul 27;18(1):238. doi: 10.1186/s12888-018-1820-x.

17.

Mindfulness for children with ADHD and Mindful Parenting (MindChamp): Protocol of a randomised controlled trial comparing a family Mindfulness-Based Intervention as an add-on to care-as-usual with care-as-usual only.

Siebelink NM, Bögels SM, Boerboom LM, de Waal N, Buitelaar JK, Speckens AE, Greven CU.

BMC Psychiatry. 2018 Jul 25;18(1):237. doi: 10.1186/s12888-018-1811-y.

18.

Decision making and support available to individuals considering and undertaking electroconvulsive therapy (ECT): a qualitative, consumer-led study.

Wells K, Scanlan JN, Gomez L, Rutter S, Hancock N, Tuite A, Ho J, Jacek S, Jones A, Mehdi H, Still M, Halliday G.

BMC Psychiatry. 2018 Jul 24;18(1):236. doi: 10.1186/s12888-018-1813-9.

19.

Reasons for living and dying in suicide attempters: a two-year prospective study.

Brüdern J, Stähli A, Gysin-Maillart A, Michel K, Reisch T, Jobes DA, Brodbeck J.

BMC Psychiatry. 2018 Jul 20;18(1):234. doi: 10.1186/s12888-018-1814-8.

20.

Supplemental Content

Loading ...
Support Center